155 related articles for article (PubMed ID: 38612962)
1. The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study.
Huss L; Gulz-Haake I; Nilsson E; Tryggvadottir H; Nilsson L; Nodin B; Jirström K; Isaksson K; Jernström H
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612962
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor expression in invasive breast tumors and breast cancer survival.
Huss L; Butt ST; Borgquist S; Elebro K; Sandsveden M; Rosendahl A; Manjer J
Breast Cancer Res; 2019 Jul; 21(1):84. PubMed ID: 31358030
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein.
Ding P; Du X; Wan L; Zhao X; Zhang D; Huang Z; Cao G; Zhou X; Zheng Y; Cao Y
Oncol Res Treat; 2022; 45(4):166-177. PubMed ID: 34818655
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis.
Xu H; Liu Z; Shi H; Wang C
BMC Cancer; 2020 Nov; 20(1):1051. PubMed ID: 33131491
[TBL] [Abstract][Full Text] [Related]
5. Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis: a prospective cohort study.
Lindgren H; Ademi D; Godina C; Tryggvadottir H; Isaksson K; Jernström H
Cancer Causes Control; 2024 Feb; ():. PubMed ID: 38351438
[TBL] [Abstract][Full Text] [Related]
6. Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.
Al-Azhri J; Zhang Y; Bshara W; Zirpoli G; McCann SE; Khoury T; Morrison CD; Edge SB; Ambrosone CB; Yao S
Clin Cancer Res; 2017 Jan; 23(1):97-103. PubMed ID: 27407090
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor.
Li Y; Cook KL; Yu W; Jin L; Bouker KB; Clarke R; Hilakivi-Clarke L
Nutrients; 2021 May; 13(5):. PubMed ID: 34069442
[TBL] [Abstract][Full Text] [Related]
8. Levels of Vitamin D and Expression of the Vitamin D Receptor in Relation to Breast Cancer Risk and Survival.
Huss L; Butt ST; Borgquist S; Elebro K; Sandsveden M; Manjer J; Rosendahl A
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014861
[TBL] [Abstract][Full Text] [Related]
9. The association between vitamin D receptor expression and prolonged overall survival in breast cancer.
Ditsch N; Toth B; Mayr D; Lenhard M; Gallwas J; Weissenbacher T; Dannecker C; Friese K; Jeschke U
J Histochem Cytochem; 2012 Feb; 60(2):121-9. PubMed ID: 22108646
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-α) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.
Hemida MA; AbdElmoneim NA; Hewala TI; Rashad MM; Abdaallah S
Clin Breast Cancer; 2019 Jun; 19(3):e407-e414. PubMed ID: 30833174
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients.
Zhang X; Hofmann S; Rack B; Harbeck N; Jeschke U; Sixou S
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632174
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor (VDR) expression is not a prognostic factor in breast cancer.
Friedrich M; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrat J; Axt-Fliedner R
Anticancer Res; 2002; 22(3):1919-24. PubMed ID: 12168894
[TBL] [Abstract][Full Text] [Related]
13. Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality.
Zati Zehni A; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731733
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanism of Cancer Susceptibility Associated with Fok1 Single Nucleotide Polymorphism of VDR in Relation to Breast Cancer.
Raza S; Dhasmana A; Bhatt MLB; Lohani M; Arif JM
Asian Pac J Cancer Prev; 2019 Jan; 20(1):199-206. PubMed ID: 30678432
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D pathway related polymorphisms and vitamin D receptor expression in breast cancer.
Francis I; AlAbdali N; Kapila K; John B; Al-Temaimi RA
Int J Vitam Nutr Res; 2021 Jan; 91(1-2):124-132. PubMed ID: 31623531
[No Abstract] [Full Text] [Related]
16. Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.
Heublein S; Mayr D; Meindl A; Kircher A; Jeschke U; Ditsch N
J Exp Clin Cancer Res; 2017 Apr; 36(1):57. PubMed ID: 28427429
[TBL] [Abstract][Full Text] [Related]
17. Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer.
Srinivasan M; Parwani AV; Hershberger PA; Lenzner DE; Weissfeld JL
J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):30-6. PubMed ID: 20955794
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Value of VDR and CTLA 4 in Evaluating the Prognosis of Invasive Duct Carcinoma of Egyptian Patients and their Benefit as a Target Therapy.
Holah NS
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1183-1194. PubMed ID: 33906311
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women.
Mishra DK; Wu Y; Sarkissyan M; Sarkissyan S; Chen Z; Shang X; Ong M; Heber D; Koeffler HP; Vadgama JV
PLoS One; 2013; 8(3):e57967. PubMed ID: 23554871
[TBL] [Abstract][Full Text] [Related]
20. Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Bahador M; Saeedi Nejad M; Dabiri S; Larizadeh MH; Soofiabadi MF
J Egypt Natl Canc Inst; 2024 Apr; 36(1):12. PubMed ID: 38616231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
